EODData

MEMBERSHIP REGISTER LOG IN

NYSE, CRL: Charles River Laboratories Intl

07 Nov 25 15:59
LAST:

168.1

CHANGE:
 2.83		OPEN:
170.9		HIGH:
171.5		ASK:
108.2		VOLUME:
416.7K
CHG(%):
1.66		PREV:
170.9		LOW:
165.7		BID:
108.2		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
07 Nov 25168.9171.5165.7168.1900.9K
06 Nov 25167.7175.0165.7170.91.91M
05 Nov 25163.3170.1160.0167.72.83M
04 Nov 25176.0180.2175.8177.91.17M
03 Nov 25178.5178.9173.9178.9670.7K
31 Oct 25178.4181.6178.2180.1950.2K
30 Oct 25177.1182.1177.1179.1784.7K
29 Oct 25186.7191.4175.6180.21.59M
28 Oct 25193.5193.5187.0187.91.1M
27 Oct 25197.2198.0193.4195.3937.1K

COMPANY PROFILE

Name:Charles River Laboratories Intl
About:Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of preclinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies. It utilizes Logica, a platform offering from Valo Health, to identify advanceable small molecule leads. It provides contract vivarium operation services to biopharmaceutical clients. The company has strategic collaborations with Parker Institute for Cancer Immunotherapy and Children's Hospital Los Angeles across its contract development and manufacturing organization. The company was founded in 1947 and is headquartered in Wilmington, Massachusetts.
Sector:Healthcare
Address:251 Ballardvale Street, Wilmington, MA, United States, 01887
Website:https://www.criver.com
CUSIP:159864107
CIK:0001100682
ISIN:US1598641074
FIGI:BBG000BG5BL8
LEI:549300BSQ0R4UZ5KX287

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:681.33 
Forward P/E:17.40 
PEG Ratio:-17.28 
Price to Sales:2.19 
Price to Book:2.62 
Profit Margin:-0.02 
Operating Margin:0.17 
Return on Assets:0.04 
Return on Equity:-0.02 
EPS Ratio:-1.30 
Revenue:4.029B 
EBITDA:796.14M 
Shares:49.21M 
Market Cap:8.27B 

TECHNICAL INDICATORS

MA5:172.672.7%
MA10:178.596.3%
MA20:179.917.1%
MA50:167.950.1%
MA100:163.362.9%
MA200:154.628.7%
STO9:1.36 
STO14:1.10 
RSI14:34.73 
WPR14:-98.81 
MTM14:-20.21
ROC14:-0.11 
ATR:7.82 
Week High:181.568.0%
Week Low:160.015.0%
Month High:199.6618.8%
Month Low:160.018.7%
Year High:222.1032.2%
Year Low:91.8682.9%

RECENT DIVIDENDS

Date Amount
28 Nov 1996$0.10
29 Oct 1996$0.10
26 Sep 1996$0.10
28 Aug 1996$0.10
29 Jul 1996$0.10
26 Jun 1996$0.10
29 May 1996$0.10
26 Apr 1996$0.10
27 Mar 1996$0.10
27 Dec 1995$0.10